In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Biohaven Ltd (NYSE: BHVN) was $15.25 for the day, down -4.75% from the previous closing price of $16.01. In other words, the price has decreased by -$4.75 from its previous closing price. On the day, 2.51 million shares were traded. BHVN stock price reached its highest trading level at $16.14 during the session, while it also had its lowest trading level at $14.99.
Ratios:
Our analysis of BHVN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.82 and its Current Ratio is at 3.82. In the meantime, Its Debt-to-Equity ratio is 2.17 whereas as Long-Term Debt/Eq ratio is at 2.13.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $65.
On September 16, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $57.Jefferies initiated its Buy rating on September 16, 2024, with a $57 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 04 ’25 when CHILDS JOHN W bought 32,700 shares for $30.47 per share. The transaction valued at 996,238 led to the insider holds 2,320,571 shares of the business.
CHILDS JOHN W bought 29,000 shares of BHVN for $1,042,393 on Dec 30 ’24. The Director now owns 2,368,741 shares after completing the transaction at $35.94 per share. On Oct 02 ’24, another insider, CHILDS JOHN W, who serves as the Director of the company, bought 21,052 shares for $47.50 each. As a result, the insider paid 999,970 and bolstered with 21,052 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 1613312768 and an Enterprise Value of 1242782976.
Stock Price History:
The Beta on a monthly basis for BHVN is 3.50, which has changed by -0.6306612 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $55.70, while it has fallen to a 52-week low of $12.79. The 50-Day Moving Average of the stock is 4.87%, while the 200-Day Moving Average is calculated to be -45.83%.
Shares Statistics:
BHVN traded an average of 2.00M shares per day over the past three months and 2045850 shares per day over the past ten days. A total of 105.78M shares are outstanding, with a floating share count of 92.38M. Insiders hold about 12.68% of the company’s shares, while institutions hold 82.69% stake in the company. Shares short for BHVN as of 1753920000 were 12714495 with a Short Ratio of 6.37, compared to 1751241600 on 12242313. Therefore, it implies a Short% of Shares Outstanding of 12714495 and a Short% of Float of 14.060001.
Earnings Estimates
The market rating for Biohaven Ltd (BHVN) is a result of the insights provided by 5.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$1.41, with high estimates of -$1.15 and low estimates of -$1.81.
Analysts are recommending an EPS of between -$5.94 and -$6.82 for the fiscal current year, implying an average EPS of -$6.28. EPS for the following year is -$5.16, with 5.0 analysts recommending between -$4.71 and -$5.67.
Revenue Estimates
Based on 15 analysts’ estimates, the company’s revenue will be $113.37M in the next fiscal year. The high estimate is $215.28M and the low estimate is $14.44M.
